Search

Anne Marie Falk

Examiner (ID: 427)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
685
Issued Applications
242
Pending Applications
153
Abandoned Applications
292

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9676675 [patent_doc_number] => 08815585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Automated method and apparatus for embryonic stem cell culture' [patent_app_type] => utility [patent_app_number] => 12/164969 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 14160 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12164969 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/164969
Automated method and apparatus for embryonic stem cell culture Jun 29, 2008 Issued
Array ( [id] => 5546653 [patent_doc_number] => 20090156530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Norepinepherine Transporter Mutants and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/146188 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29223 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156530.pdf [firstpage_image] =>[orig_patent_app_number] => 12146188 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/146188
Norepinepherine Transporter Mutants and Uses Thereof Jun 24, 2008 Abandoned
Array ( [id] => 8527667 [patent_doc_number] => 08304237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Method and device for forming biologic cell aggregates' [patent_app_type] => utility [patent_app_number] => 12/665325 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 3972 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665325 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/665325
Method and device for forming biologic cell aggregates Jun 12, 2008 Issued
Array ( [id] => 5264435 [patent_doc_number] => 20090117120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Transgenic animal model for alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 12/157664 [patent_app_country] => US [patent_app_date] => 2008-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15292 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117120.pdf [firstpage_image] =>[orig_patent_app_number] => 12157664 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/157664
Transgenic animal model for alzheimer's disease Jun 10, 2008 Issued
Array ( [id] => 6367876 [patent_doc_number] => 20100251392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'METHODS FOR ASSESSING THE DELIVERY OF EXOGENOUS AGENTS' [patent_app_type] => utility [patent_app_number] => 12/114609 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8057 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20100251392.pdf [firstpage_image] =>[orig_patent_app_number] => 12114609 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/114609
METHODS FOR ASSESSING THE DELIVERY OF EXOGENOUS AGENTS May 1, 2008 Abandoned
Array ( [id] => 8257216 [patent_doc_number] => 08206699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells' [patent_app_type] => utility [patent_app_number] => 12/111839 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 34 [patent_no_of_words] => 10351 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12111839 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/111839
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells Apr 28, 2008 Issued
Array ( [id] => 4759904 [patent_doc_number] => 20080312130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'DRUG DELIVERY VEHICLE FOR CANCER THERAPY, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATION USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/054200 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10085 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312130.pdf [firstpage_image] =>[orig_patent_app_number] => 12054200 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/054200
DRUG DELIVERY VEHICLE FOR CANCER THERAPY, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATION USING THE SAME Mar 23, 2008 Abandoned
Array ( [id] => 4927010 [patent_doc_number] => 20080166373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 12/053479 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11651 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166373.pdf [firstpage_image] =>[orig_patent_app_number] => 12053479 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/053479
METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS Mar 20, 2008 Abandoned
Array ( [id] => 4710564 [patent_doc_number] => 20080299090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Use Of Umbilical Cord Matrix Cells' [patent_app_type] => utility [patent_app_number] => 12/053167 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24159 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299090.pdf [firstpage_image] =>[orig_patent_app_number] => 12053167 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/053167
Use Of Umbilical Cord Matrix Cells Mar 20, 2008 Abandoned
Array ( [id] => 4431733 [patent_doc_number] => 07968337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Neural precursor cells, method for the production and use thereof in neural defect therapy' [patent_app_type] => utility [patent_app_number] => 12/048840 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 32 [patent_no_of_words] => 13784 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968337.pdf [firstpage_image] =>[orig_patent_app_number] => 12048840 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/048840
Neural precursor cells, method for the production and use thereof in neural defect therapy Mar 13, 2008 Issued
Array ( [id] => 6520095 [patent_doc_number] => 20100203111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'G-SUBSTRATE FOR THE TREATMENT AND PREVENTION OF PARKINSON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/531044 [patent_app_country] => US [patent_app_date] => 2008-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11408 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203111.pdf [firstpage_image] =>[orig_patent_app_number] => 12531044 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/531044
G-substrate for the treatment and prevention of parkinson's disease Mar 10, 2008 Issued
Array ( [id] => 5386415 [patent_doc_number] => 20090227660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'GLP-1 gene delivery for the treatment of type 2 diabetes' [patent_app_type] => utility [patent_app_number] => 12/074865 [patent_app_country] => US [patent_app_date] => 2008-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6805 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227660.pdf [firstpage_image] =>[orig_patent_app_number] => 12074865 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/074865
GLP-1 gene delivery for the treatment of type 2 diabetes Mar 4, 2008 Abandoned
Array ( [id] => 8352056 [patent_doc_number] => 08247385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Treatment and prevention of neurodegenerative diseases using gene therapy' [patent_app_type] => utility [patent_app_number] => 12/025684 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 15340 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12025684 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/025684
Treatment and prevention of neurodegenerative diseases using gene therapy Feb 3, 2008 Issued
Array ( [id] => 4926959 [patent_doc_number] => 20080166322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'METHODS FOR PRODUCING AN ADENOVIRUS TYPE 5 GENE TRANSFER VECTOR' [patent_app_type] => utility [patent_app_number] => 11/953306 [patent_app_country] => US [patent_app_date] => 2007-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7842 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166322.pdf [firstpage_image] =>[orig_patent_app_number] => 11953306 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/953306
METHODS FOR PRODUCING AN ADENOVIRUS TYPE 5 GENE TRANSFER VECTOR Dec 9, 2007 Abandoned
Array ( [id] => 4764616 [patent_doc_number] => 20080175827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY' [patent_app_type] => utility [patent_app_number] => 11/942406 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 23231 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175827.pdf [firstpage_image] =>[orig_patent_app_number] => 11942406 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/942406
PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY Nov 18, 2007 Abandoned
Array ( [id] => 9254856 [patent_doc_number] => 08618273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same' [patent_app_type] => utility [patent_app_number] => 12/447044 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6910 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12447044 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/447044
Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same Oct 23, 2007 Issued
Array ( [id] => 4608669 [patent_doc_number] => 07993924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses' [patent_app_type] => utility [patent_app_number] => 11/899492 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 14780 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993924.pdf [firstpage_image] =>[orig_patent_app_number] => 11899492 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/899492
cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses Sep 5, 2007 Issued
Array ( [id] => 4909697 [patent_doc_number] => 20080020463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Entrapped stem cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/891526 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3951 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020463.pdf [firstpage_image] =>[orig_patent_app_number] => 11891526 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/891526
Entrapped stem cells and uses thereof Aug 9, 2007 Issued
Array ( [id] => 6549442 [patent_doc_number] => 20100233125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'CHIMERIC ADENOVIRUS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/438238 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7940 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233125.pdf [firstpage_image] =>[orig_patent_app_number] => 12438238 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/438238
CHIMERIC ADENOVIRUS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL USING THE SAME Aug 8, 2007 Abandoned
Array ( [id] => 4803574 [patent_doc_number] => 20080015163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'MICE LACKING ALPHA 1G SHOWING ENHANCED NOVELTY-SEEKING AND ALCOHOL PREFERENCE AND THERAPEUTIC METHODS FOR MOOD DISORDERS BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS' [patent_app_type] => utility [patent_app_number] => 11/782771 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6582 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015163.pdf [firstpage_image] =>[orig_patent_app_number] => 11782771 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/782771
MICE LACKING ALPHA 1G SHOWING ENHANCED NOVELTY-SEEKING AND ALCOHOL PREFERENCE AND THERAPEUTIC METHODS FOR MOOD DISORDERS BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS Jul 24, 2007 Abandoned
Menu